Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Moore

Showing results (231-240 of 276) with videos related to

Pageof 28
Sort By:
Bone Marrow Transplantation|April 20, 2022
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRRDavid Kliman, Steven Tran, Glen Kennedy, et al.
Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.
British Journal of Anaesthesia|April 3, 2024
Outcomes reported in randomised trials of surgical prehabilitation: a scoping reviewChloé Fleurent-Grégoire, Nicola Burgess, Linda Denehy, et al.
Cytokine|January 12, 2010
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markersSarah C Sasson, Sandy Smith, Nabila Seddiki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional TherapyKate Gregory, Dylan Hansen, Ross Penglase, et al.
BMJ Open|June 14, 2022
RadBone: bone toxicity following pelvic radiotherapy - a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapyVictoria Chatzimavridou Grigoriadou, Lisa H Barraclough, Ivona Baricevic-Jones, et al.
The Lancet. Oncology|January 3, 2016
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
The Lancet. Haematology|January 21, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
MMWR Supplements|June 12, 2014
Youth risk behavior surveillance--United States, 2013Laura Kann, Steve Kinchen, Shari L Shanklin, et al.
Plos Medicine|August 15, 2008
The use of nonhuman primate models in HIV vaccine developmentCecilia Morgan, Marta Marthas, Christopher Miller, et al.
Pageof 28

Showing results (231-240 of 276) with videos related to

Sort By:
Pageof 28
Bone Marrow Transplantation|April 20, 2022
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRRDavid Kliman, Steven Tran, Glen Kennedy, et al.
Arthritis and Rheumatism|October 2, 2002
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritisJohn Moore, Peter Brooks, Sam Milliken, et al.
British Journal of Anaesthesia|April 3, 2024
Outcomes reported in randomised trials of surgical prehabilitation: a scoping reviewChloé Fleurent-Grégoire, Nicola Burgess, Linda Denehy, et al.
Cytokine|January 12, 2010
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markersSarah C Sasson, Sandy Smith, Nabila Seddiki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional TherapyKate Gregory, Dylan Hansen, Ross Penglase, et al.
BMJ Open|June 14, 2022
RadBone: bone toxicity following pelvic radiotherapy - a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapyVictoria Chatzimavridou Grigoriadou, Lisa H Barraclough, Ivona Baricevic-Jones, et al.
The Lancet. Oncology|January 3, 2016
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
The Lancet. Haematology|January 21, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
MMWR Supplements|June 12, 2014
Youth risk behavior surveillance--United States, 2013Laura Kann, Steve Kinchen, Shari L Shanklin, et al.
Plos Medicine|August 15, 2008
The use of nonhuman primate models in HIV vaccine developmentCecilia Morgan, Marta Marthas, Christopher Miller, et al.
Pageof 28